Hormone therapy after risk-reducing surgery in patients with BRCA1/BRCA2 mutation: evaluation of potential benefits

Agnaldo Lopes da Silva Filho1, Gabriella Martins Carvalho2, Larissa Cristelli de Sena2

  • 1. Professor Titular do Departamento de Ginecologia e Obstetrícia da UFMG, Belo Horizonte, MG, Brasil.

Revista Da Associacao Medica Brasileira (1992)
|September 16, 2020
PubMed